The former workers cited various reasons why they think Novo was cautious: its conservative culture and history of investing ...

And it’s never a bad time to re-read some of the team’s excellent, award-winning coverage on the company: Last week, key ...

Exclusive: OpenEvidence aims to be ‘Disney+’ with new JAMA deal. OpenEvidence this morning announced it has a new multi-year ...

In the late 2010s, Novo Nordisk shelved a weekly obesity treatment that targeted three hormones at once, though it caused notable weight loss in mice ...

MoonLake Immunotherapeutics is for sale? This sounds like a cry for help, STAT's Adam Feuerstein writes.

Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...

The rewriting of government recommendations will make the effort to get vaccine doses into arms exponentially more difficult, ...

The NIH archives of the Human Genome Project could fall victim to Trump administration cuts, writes a former archivist.

An internal document reveals how UnitedHealth Group's leadership prepared to downplay complaints about its business practices ...

WASHINGTON — House Republicans’ tax bill would lead to nearly 11 million people losing health insurance, providing a key ...

Merck, as it prepares a new version of its cancer blockbuster Keytruda, gets a boost in its patent dispute with Halozyme ...

During his confirmation hearings, Kennedy promised that he would not interfere with established immunization schedules. His ...